Cargando…

Regular Exercise Modifies Histopathological Outcomes of Pharmacological Treatment in Experimental Autoimmune Encephalomyelitis

Background: Although it has been suggested that healthier lifestyle may optimize effects of the immunomodulation drugs for treating multiple sclerosis (MS), the knowledge regarding this kind of interactions is limited. Objective: The aim of the present study was to investigate the effects of treadmi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bernardes, Danielle, de Oliveira, Alexandre Leite Rodrigues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256135/ https://www.ncbi.nlm.nih.gov/pubmed/30524355 http://dx.doi.org/10.3389/fneur.2018.00950

Ejemplares similares

Gliosis attenuation in experimental autoimmune encephalomyelitis by a combination of dimethyl fumarate and pregabalin
por: Hoelz, Amanda Garcia, et al.
Publicado: (2022)

Editorial: Pain in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Lovett-Racke, Amy, et al.
Publicado: (2022)

A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis
por: Gibson-Corley, Katherine N., et al.
Publicado: (2016)

Systemic Acrolein Elevations in Mice With Experimental Autoimmune Encephalomyelitis and Patients With Multiple Sclerosis
por: Tully, Melissa, et al.
Publicado: (2018)

Dietary protection against the visual and motor deficits induced by experimental autoimmune encephalomyelitis
por: Zyla-Jackson, Katarzyna, et al.
Publicado: (2023)

Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction
por: Boziki, Marina, et al.
Publicado: (2023)

Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment
por: Jayaraman, Sundararajan, et al.
Publicado: (2022)

Therapeutic potential of blocking GAPDH nitrosylation with CGP3466b in experimental autoimmune encephalomyelitis
por: Godfrey, Wesley H., et al.
Publicado: (2023)

Clinical and Histopathological Assessment on an Animal Model with Experimental Autoimmune Encephalomyelitis
por: TOADER, L.E., et al.
Publicado: (2018)

Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation
por: Yang, Huan-Li, et al.
Publicado: (2021)

Anti-IL-6 Receptor Antibody Inhibits Spontaneous Pain at the Pre-onset of Experimental Autoimmune Encephalomyelitis in Mice
por: Serizawa, Kenichi, et al.
Publicado: (2019)

Rapamycin Alleviates the Symptoms of Multiple Sclerosis in Experimental Autoimmune Encephalomyelitis (EAE) Through Mediating the TAM-TLRs-SOCS Pathway
por: Li, Xiao-ling, et al.
Publicado: (2020)

In-Depth Characterization of Somatic and Orofacial Sensitive Dysfunctions and Interfering-Symptoms in a Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mouse Model
por: Démosthènes, Amélie, et al.
Publicado: (2022)

Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells
por: Mathisen, Peter M., et al.
Publicado: (1997)

Chloroquine Treatment Enhances Regulatory T Cells and Reduces the Severity of Experimental Autoimmune Encephalomyelitis
por: Thomé, Rodolfo, et al.
Publicado: (2013)

A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Role of SOCS2 in the Regulation of Immune Response and Development of the Experimental Autoimmune Encephalomyelitis
por: Cramer, Allysson, et al.
Publicado: (2019)

Corrigendum: A Perspective of Coagulation Dysfunction in Multiple Sclerosis and in Experimental Allergic Encephalomyelitis
por: Plantone, Domenico, et al.
Publicado: (2019)

Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation
por: Fraga-Silva, Thais Fernanda de Campos, et al.
Publicado: (2019)

Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)

Environmental Influences in Experimental Autoimmune Encephalomyelitis
por: Constantinescu, Cris S
Publicado: (2005)

Comprehensive catwalk gait analysis in a chronic model of multiple sclerosis subjected to treadmill exercise training
por: Bernardes, Danielle, et al.
Publicado: (2017)

Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis
por: Juźwik, Camille A., et al.
Publicado: (2018)

Erythropoietin and autoimmune neuroinflammation: lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis
por: Shin, Taekyun, et al.
Publicado: (2012)

Pharmacokinetics of the Yougui pill in experimental autoimmune encephalomyelitis model rats and its pharmacological activity in vitro
por: Liu, Haolong, et al.
Publicado: (2019)

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
por: Miralles, Marta, et al.
Publicado: (2017)

Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2022)

Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis
por: Liu, Chunyun, et al.
Publicado: (2023)

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis
por: Girolamo, Francesco, et al.
Publicado: (2014)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis
por: Lutz, Sarah E., et al.
Publicado: (2013)

The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis
por: Birkner, Katharina, et al.
Publicado: (2017)

Amelioration of experimental autoimmune encephalomyelitis by Ishige okamurae
por: Ahn, Meejung, et al.
Publicado: (2018)

Oryeongsan (Goreisan) Ameliorates Experimental Autoimmune Encephalomyelitis
por: Inada, Rino, et al.
Publicado: (2019)

Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis
por: Saligrama, Naresha, et al.
Publicado: (2019)

Molecular effects of curcumin on the experimental autoimmune encephalomyelitis
por: Mavaddatiyan, Laleh, et al.
Publicado: (2021)

Exercise training alters autoimmune cell invasion into the brain in autoimmune encephalomyelitis
por: Hamdi, Liel, et al.
Publicado: (2022)

Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis
por: Teixeira, Nathalia Bernardes, et al.
Publicado: (2020)

Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels
por: Halder, Sebok K., et al.
Publicado: (2018)

Nasal delivery of Fasudil‐modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis
por: Guo, Shang‐De, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ip5768bvd0e3qoa4h7p9nh176f